Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients.

PLoS One · 2021 · PMC8330918 · PMID 34343191

Europe PMC DOI

hedged sentence

0.0509

closest p · 1.0× alpha

0.0509

boldest claim

The sentences

approaching significancep = 0.0509so close (0.05 < p ≤ 0.1)

ICU admissions were lower in SARS-CoV-2-positive patients receiving the influenza vaccine at 30, 90, and 120 days (p<0.03, RR: 1.174–1.200, 95% CI:1.003–1.385, NNT:435), while approaching significance at 60 days (p = 0.0509, RR: 1.156, 95% CI:0.999–1.338).

also in 2,640 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.